- Home
- SBAC vs BNTX Comparison
SBAC vs BNTX Comparison
Compare SBAC & BNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBAC
- BNTX
- Stock Information
- Founded
- SBAC 1989
- BNTX 2008
- Country
- SBAC United States
- BNTX Germany
- Employees
- SBAC N/A
- BNTX N/A
- Industry
- SBAC Real Estate Investment Trusts
- BNTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- SBAC Real Estate
- BNTX Health Care
- Exchange
- SBAC Nasdaq
- BNTX Nasdaq
- Market Cap
- SBAC 25.1B
- BNTX 26.4B
- IPO Year
- SBAC 1999
- BNTX 2019
- Fundamental
- Price
- SBAC $229.98
- BNTX $112.71
- Analyst Decision
- SBAC Buy
- BNTX Strong Buy
- Analyst Count
- SBAC 14
- BNTX 18
- Target Price
- SBAC $254.71
- BNTX $141.60
- AVG Volume (30 Days)
- SBAC 697.0K
- BNTX 731.1K
- Earning Date
- SBAC 07-28-2025
- BNTX 08-04-2025
- Dividend Yield
- SBAC 1.91%
- BNTX N/A
- EPS Growth
- SBAC 48.26
- BNTX N/A
- EPS
- SBAC 7.56
- BNTX N/A
- Revenue
- SBAC $2,686,020,000.00
- BNTX $2,968,331,171.00
- Revenue This Year
- SBAC $4.53
- BNTX N/A
- Revenue Next Year
- SBAC $4.71
- BNTX $10.68
- P/E Ratio
- SBAC $30.25
- BNTX N/A
- Revenue Growth
- SBAC N/A
- BNTX 0.61
- 52 Week Low
- SBAC $192.55
- BNTX $76.53
- 52 Week High
- SBAC $252.64
- BNTX $131.49
- Technical
- Relative Strength Index (RSI)
- SBAC 45.17
- BNTX 63.00
- Support Level
- SBAC $230.73
- BNTX $105.35
- Resistance Level
- SBAC $235.23
- BNTX $114.00
- Average True Range (ATR)
- SBAC 4.94
- BNTX 2.62
- MACD
- SBAC -0.31
- BNTX 0.53
- Stochastic Oscillator
- SBAC 14.70
- BNTX 89.37
About SBAC SBA Communications Corporation
SBA Communications owns and operates almost 40,000 cell towers throughout North America, South America, and Africa. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company has a very concentrated customer base, with most revenue in each market being generated by just the top few mobile carriers. It owns more than 17,000 towers in the US, which accounted for about 70% of the company's total revenue in 2023. Internationally, SBA's greatest presence is in Brazil, where it operates roughly 10,000 towers. SBA operates as a real estate investment trust.
About BNTX BioNTech SE
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.